Prestige Consumer Healthcare
355 hedge funds and large institutions have $3.08B invested in Prestige Consumer Healthcare in 2026 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 133 increasing their positions, 129 reducing their positions, and 44 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
25% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 44
2.49% more ownership
Funds ownership: 107.36% → 109.85% (+2.5%)
3% more repeat investments, than reductions
Existing positions increased: 133 | Existing positions reduced: 129
0% more funds holding
Funds holding: 354 → 355 (+1)
3% less capital invested
Capital invested by funds: $3.18B → $3.08B (-$107M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $12K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Silvercrest Asset Management
New York
|
+$31.2M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$21.6M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$17.8M |
| 4 |
Jones Financial Companies
Des Peres,
Missouri
|
+$16.2M |
| 5 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$16.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NAMI
Nomura Asset Management International
Philadelphia,
Pennsylvania
|
-$22.8M |
| 2 |
Squarepoint
New York
|
-$17.9M |
| 3 |
BlackRock
New York
|
-$17.7M |
| 4 |
D.E. Shaw & Co
New York
|
-$5.98M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$5.01M |
PBH Hedge Fund Activity: Q1 2026 in Review
355 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q1 2026, worth a combined $3.08B — down 3.4% from $3.18B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new PBH positions and 44 closed out — a net gain of 11 holders — while 133 added to existing stakes and 129 trimmed.
The largest buyer was Silvercrest Asset Management, opening a new position worth an estimated $31.2M. The largest seller was Nomura Asset Management International, cutting an estimated $22.8M.
- 355 institutional investors held Prestige Consumer Healthcare (PBH) as of Q1 2026, up from 354 in Q4 2025.
- Funds reported $3.08B of Prestige Consumer Healthcare stock for Q1 2026, down 3.4% quarter-over-quarter.
- 55 funds opened new Prestige Consumer Healthcare positions in Q1 2026 and 44 closed out, a net change of +11 holders.
- The largest Prestige Consumer Healthcare buyer in Q1 2026 was Silvercrest Asset Management, an estimated $31.2M added.
- The largest Prestige Consumer Healthcare seller in Q1 2026 was Nomura Asset Management International, an estimated $22.8M sold.
Based on aggregated 13F filings for Q1 2026.